Ola B, Afnan M, Sharif K, Hammadieh N, Papaioannou S, Coomarasamy A. Cost-Effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view? Acta Obstet Gynecol Scand 2001, Dec;80(12):1141-2.
Hammadieh N, Sharif K, Afnan M, Papaioannou S, Ola B. Beware of cytogenetic results after successful bone marrow transplantation. BMJ 2001, Aug 4;323(7307):285. Ola B, Papaioannou S, Afnan MA, Hammadieh N, Gimba S. Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis. Fertil Steril 2001, Jun;75(6):1106-10.
Papaionnou S, Afnan M, Ola B, Coomarasamy A, Hammadieh N, Sharif K. Validity of comparisons? Fertil Steril 2001, Aug;76(2):427-8.
Papaioannou S, Afnan M, Coomarasamy A, Ola B, Hammadieh N, Sharif K. The use of repeat hysterosalpingography. Fertil Steril 2001, Oct;76(4):849-50.
Sakkas D, Percival G, D’Arcy Y, Sharif K, Afnan M. Assessment of early cleaving in vitro fertilized human embryos at the 2-cell stage before transfer improves embryo selection. Fertil Steril 2001, Dec;76(6):1150-6.
